Further evidence for ultraviolet light induction of CDKN2 (p16INK4) mutations in sporadic melanoma in vivo.
Herbst
R A
RA
Gutzmer
R
R
Matiaske
F
F
Mommert
S
S
Kapp
A
A
Weiss
J
J
Arden
K C
KC
Cavenee
W K
WK
D000409:Alanine / Q000032:analysis; D000483:Alleles; D001120:Arginine / Q000032:analysis; D002352:Carrier Proteins / Q000032:analysis / Q000235:genetics* / Q000378:metabolism; D019941:Cyclin-Dependent Kinase Inhibitor p16; D004273:DNA, Neoplasm / Q000032:analysis / Q000737:chemistry / Q000235:genetics*; D004791:Enzyme Inhibitors / Q000032:analysis* / Q000378:metabolism; D005091:Exons; D006579:Heterozygote; D006801:Humans; D007930:Leucine / Q000032:analysis; D008545:Melanoma / Q000737:chemistry / Q000209:etiology / Q000235:genetics*; D009154:Mutation; D016133:Polymerase Chain Reaction; D012867:Skin / Q000737:chemistry / Q000473:pathology / Q000528:radiation effects; D012878:Skin Neoplasms / Q000737:chemistry / Q000209:etiology / Q000235:genetics*; D014466:Ultraviolet Rays; D014633:Valine / Q000032:analysis
D002352:Carrier Proteins; D019941:Cyclin-Dependent Kinase Inhibitor p16; D004273:DNA, Neoplasm; D004791:Enzyme Inhibitors; D001120:Arginine; D007930:Leucine; D014633:Valine; D000409:Alanine